SPYRE THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
SPYRE THERAPEUTICS, INC. (SYRE) reported Increase (Decrease) in Accounts Payable of $2.04 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-08-11
- SPYRE THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2023-06-30 was $661.00K.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2023-03-31 was $1.38M.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2022-12-31 was -$3.50M, a 340.55% decline year-over-year.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was $2.21M.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was -$2.64M, a 347.98% decline from fiscal 2021.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2021 was $1.06M.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2020 was -$544.00K, a 121.06% decline from fiscal 2019.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2019 was $2.58M, a 980.75% increase from fiscal 2018.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2023-06-30 | $661.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $2.04M 10-Q · filed 2023-08-11 | -$1.46M derived: sum of 3 quarters · filed 2023-08-11 | $756.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $1.38M 10-Q · filed 2023-05-11 | -$2.12M derived: sum of 2 quarters · filed 2023-05-11 | $95.00K derived: sum of 3 quarters · filed 2023-05-11 | -$919.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | -$3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$1.29M derived: sum of 2 quarters · filed 2023-03-02 | -$2.30M derived: sum of 3 quarters · filed 2023-08-11 | -$2.64M 10-K · filed 2023-03-02 |
| 2022-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.20M derived: sum of 2 quarters · filed 2023-08-11 | $859.00K 10-Q · filed 2022-11-03 | $2.31M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$1.35M 10-Q · filed 2023-08-11 | $103.00K derived: sum of 3 quarters · filed 2023-08-11 | -$232.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$338.00K 10-Q · filed 2023-05-11 | $1.12M derived: sum of 2 quarters · filed 2023-05-11 | $782.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.10M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.12M derived: sum of 2 quarters · filed 2023-03-02 | $1.44M derived: sum of 3 quarters · filed 2023-03-02 | $1.06M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$335.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$14.00K derived: sum of 2 quarters · filed 2022-11-03 | -$390.00K 10-Q · filed 2022-11-03 | -$395.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$55.00K 10-Q · filed 2022-08-04 | -$60.00K derived: sum of 3 quarters · filed 2023-03-02 | -$1.92M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | -$376.00K 10-Q · filed 2022-05-05 | -$381.00K derived: sum of 2 quarters · filed 2023-03-02 | -$2.24M derived: sum of 3 quarters · filed 2023-03-02 | -$1.18M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$1.86M derived: sum of 2 quarters · filed 2023-03-02 | -$806.00K derived: sum of 3 quarters · filed 2023-03-02 | -$544.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$801.00K derived: sum of 2 quarters · filed 2021-11-04 | -$539.00K 10-Q · filed 2021-11-04 | $210.00K derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.32M 10-Q · filed 2021-08-05 | $2.07M derived: sum of 3 quarters · filed 2022-03-08 | $1.76M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $262.00K 10-Q · filed 2021-05-10 | $1.01M derived: sum of 2 quarters · filed 2022-03-08 | $704.00K derived: sum of 3 quarters · filed 2022-03-08 | $556.00K derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $749.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $442.00K derived: sum of 2 quarters · filed 2022-03-08 | $294.00K derived: sum of 3 quarters · filed 2022-03-08 | $2.58M 10-K · filed 2022-03-08 |
| 2019-09-30 | -$307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$455.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.83M 10-Q · filed 2020-11-05 | $1.35M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | -$148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.14M 10-Q · filed 2020-08-10 | $1.65M derived: sum of 3 quarters · filed 2021-03-18 | $1.80M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | $2.29M 10-Q · filed 2020-05-07 | $1.80M derived: sum of 2 quarters · filed 2021-03-18 | $1.95M derived: sum of 3 quarters · filed 2021-03-18 | $2.13M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | -$488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$340.00K derived: sum of 2 quarters · filed 2021-03-18 | -$157.00K derived: sum of 3 quarters · filed 2021-03-18 | $239.00K 10-K · filed 2021-03-18 |
| 2018-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $331.00K derived: sum of 2 quarters · filed 2019-11-06 | $727.00K 10-Q · filed 2019-11-06 | $444.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $579.00K 10-Q · filed 2019-08-06 | $296.00K derived: sum of 3 quarters · filed 2020-02-24 | $403.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $396.00K 10-Q · filed 2019-05-07 | $113.00K derived: sum of 2 quarters · filed 2020-02-24 | $220.00K derived: sum of 3 quarters · filed 2020-02-24 | $465.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | -$283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$176.00K derived: sum of 2 quarters · filed 2020-02-24 | $69.00K derived: sum of 3 quarters · filed 2020-02-24 | $164.00K 10-K · filed 2020-02-24 |
| 2017-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $352.00K derived: sum of 2 quarters · filed 2018-11-08 | $447.00K 10-Q · filed 2018-11-08 | $92.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $340.00K 10-Q · filed 2018-08-09 | -$15.00K derived: sum of 3 quarters · filed 2019-03-07 | $160.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $95.00K 10-Q · filed 2018-05-08 | -$260.00K derived: sum of 2 quarters · filed 2019-03-07 | -$85.00K derived: sum of 3 quarters · filed 2019-03-07 | -$174.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | -$355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$180.00K derived: sum of 2 quarters · filed 2019-03-07 | -$269.00K derived: sum of 3 quarters · filed 2019-03-07 | -$8.00K 10-K · filed 2019-03-07 |
| 2016-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $86.00K derived: sum of 2 quarters · filed 2017-11-07 | $347.00K 10-Q · filed 2017-11-07 | -$39.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-06-30 | -$89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $172.00K 10-Q · filed 2017-08-09 | -$214.00K derived: sum of 3 quarters · filed 2018-03-13 | -$441.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-03-31 | $261.00K 10-Q · filed 2017-05-09 | -$125.00K derived: sum of 2 quarters · filed 2018-03-13 | -$352.00K derived: sum of 3 quarters · filed 2018-03-13 | $110.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2015-12-31 | -$386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$613.00K derived: sum of 2 quarters · filed 2018-03-13 | -$151.00K derived: sum of 3 quarters · filed 2018-03-13 | -$169.00K 10-K · filed 2018-03-13 |
| 2015-09-30 | -$227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $235.00K derived: sum of 2 quarters · filed 2016-11-09 | $217.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $444.00K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$18.00K 10-Q · filed 2016-05-19 | |||
| 2014-12-31 | -$165.00K 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |